MW 421.5 Da, Purity >98%. Potent, selective TGF-β type I receptor ALK5, type I activin/nodal receptor ALK4 and type I nodal receptor ALK7 kinase inhibitor (IC50 values are 12, 45 and 7.5 nM for ALK5, ALK4 and ALK7 respectively). TGF-β1 inhibitor. Inhibits TGF-β1-dependent α-SMA and collagen type I induction. Active in vivo and in vitro.
ARVD, ARVD1, BSC-1 cell growth inhibitor, CED, Cartilage-inducing factor, Cellular Yes 1 protein, Cetermin, DPD1, Differentiation inhibiting factor, FLJ16571, G-TSF, Glioblastoma-derived T-cell suppressor factor, HsT441, LAP, LDS5, Latency-associated peptide, MGC105479, MGC116892, MGC118722, MGF, Milk growth factor, Polyergin, Prepro transforming growth factor beta 1, Proto oncogene tyrosine protein kinase YES, Proto-oncogene c-Yes, RNHF, TGF beta, TGF-beta 1 protein, TGF-beta-1, TGF-beta-2, TGF-beta-3, TGF-beta-5, TGFB, TGFB1_HUMAN, TGFB2_HUMAN, TGFB3_HUMAN, Transforming Growth Factor b1, Transforming Growth Factor beta-1, Transforming Growth Factor-鑴1, Transforming growth factor beta 1a, Transforming growth factor beta 2, Transforming growth factor beta-3, Tyrosine-protein kinase Yes, Viral oncogene yes 1 homolog 1, YES proto oncogene 1, Src family tyrosine kinase, YES1 proto oncogene, Src family tyrosine kinase, YES_HUMAN, Yamaguchi sarcoma oncogene, Yes 1, c Yes, p61-Yes, prepro-transforming growth factor beta-3, v yes 1 Yamaguchi sarcoma viral oncogene homolog 1
MW 421.5 Da, Purity >98%. Potent, selective TGF-β type I receptor ALK5, type I activin/nodal receptor ALK4 and type I nodal receptor ALK7 kinase inhibitor (IC50 values are 12, 45 and 7.5 nM for ALK5, ALK4 and ALK7 respectively). TGF-β1 inhibitor. Inhibits TGF-β1-dependent α-SMA and collagen type I induction. Active in vivo and in vitro.
Potent, selective TGF-β type I receptor ALK5, type I activin/nodal receptor ALK4 and type I nodal receptor ALK7 kinase inhibitor (IC50 values are 12, 45 and 7.5 nM for ALK5, ALK4 and ALK7 respectively). TGF-β1 inhibitor. Inhibits TGF-β1-dependent α-SMA and collagen type I induction. Active in vivo and in vitro.
This product is manufactured by BioVision, an Abcam company and was previously called 1725 A 83-01. 1725-1 is the same size as the 1 mg size of ab142092.
Handling
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Refer to SDS for further information.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2D chemical structure image of ab142092, A 83-01, ALK4, 5 and 7 kinase inhibitor
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com